You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Caplin Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for CAPLIN, and what generic and branded alternatives to CAPLIN drugs are available?

CAPLIN has twenty-five approved drugs.

There is one tentative approval on CAPLIN drugs.

Summary for Caplin

US Patents:	0
Tradenames:	22
Ingredients:	22
NDAs:	25

Drugs and US Patents for Caplin

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Caplin	SODIUM NITROPRUSSIDE	sodium nitroprusside	INJECTABLE;INJECTION	211016-001	Nov 29, 2019	AP	RX	No	No		⤷ Subscribe				⤷ Subscribe
Caplin	ROCURONIUM BROMIDE	rocuronium bromide	INJECTABLE;INJECTION	216234-002	Mar 2, 2023	AP	RX	No	No		⤷ Subscribe				⤷ Subscribe
Caplin	CISATRACURIUM BESYLATE	cisatracurium besylate	INJECTABLE;INJECTION	217725-002	Jun 9, 2023		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Caplin	PHENYLEPHRINE HYDROCHLORIDE	phenylephrine hydrochloride	SOLUTION/DROPS;OPHTHALMIC	215183-001	May 23, 2024	AT	RX	No	No		⤷ Subscribe				⤷ Subscribe
Caplin	ROCURONIUM BROMIDE	rocuronium bromide	INJECTABLE;INJECTION	216234-001	Mar 2, 2023	AP	RX	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for CAPLIN drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Injection	1 mg/mL, 50 mL vials	➤ Subscribe	2011-12-16
➤ Subscribe	Injection	100 mg/mL, 2.5 mL vials	➤ Subscribe	2007-09-24

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Caplin

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.